Imaging mass spectrometry: Challenges in visualization of drug distribution in solid tumors

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Mass spectrometry imaging (MSI) is an emerging technique that allows molecular visualization of the distribution of drugs and metabolites in a two-dimensional space directly in biological tissues. Imaging drug distribution inside a tumor is an important tool to support strategies to improve penetration of anticancer drugs and consequently the outcome of chemotherapy. MSI has some advantages in comparison to other imaging techniques, that is, whole body autoradiography, positron emission tomography or microscopy imaging. It is a label-free technique with better specificity and provides the possibility to combine histological data with MS ones and to visualize simultaneously the distribution of biomarkers in relation to tumor heterogeneity. We overview here publications on MSI applied to studies of the distribution of anticancer agents in tumor tissue. In addition, we focused our attention on technical limitations and future perspectives pertaining to this technique.

Original languageEnglish
Pages (from-to)807-812
Number of pages6
JournalCurrent Opinion in Pharmacology
Volume13
Issue number5
DOIs
Publication statusPublished - Oct 2013

Fingerprint

Mass Spectrometry
Pharmaceutical Preparations
Neoplasms
Autoradiography
Positron-Emission Tomography
Antineoplastic Agents
Publications
Microscopy
Biomarkers
Drug Therapy

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology

Cite this

@article{53c703fbcf1047119efbb394e1c357b0,
title = "Imaging mass spectrometry: Challenges in visualization of drug distribution in solid tumors",
abstract = "Mass spectrometry imaging (MSI) is an emerging technique that allows molecular visualization of the distribution of drugs and metabolites in a two-dimensional space directly in biological tissues. Imaging drug distribution inside a tumor is an important tool to support strategies to improve penetration of anticancer drugs and consequently the outcome of chemotherapy. MSI has some advantages in comparison to other imaging techniques, that is, whole body autoradiography, positron emission tomography or microscopy imaging. It is a label-free technique with better specificity and provides the possibility to combine histological data with MS ones and to visualize simultaneously the distribution of biomarkers in relation to tumor heterogeneity. We overview here publications on MSI applied to studies of the distribution of anticancer agents in tumor tissue. In addition, we focused our attention on technical limitations and future perspectives pertaining to this technique.",
author = "Lavinia Morosi and Massimo Zucchetti and Maurizio D'Incalci and Enrico Davoli",
year = "2013",
month = "10",
doi = "10.1016/j.coph.2013.06.003",
language = "English",
volume = "13",
pages = "807--812",
journal = "Current Opinion in Pharmacology",
issn = "1471-4892",
publisher = "Elsevier BV",
number = "5",

}

TY - JOUR

T1 - Imaging mass spectrometry

T2 - Challenges in visualization of drug distribution in solid tumors

AU - Morosi, Lavinia

AU - Zucchetti, Massimo

AU - D'Incalci, Maurizio

AU - Davoli, Enrico

PY - 2013/10

Y1 - 2013/10

N2 - Mass spectrometry imaging (MSI) is an emerging technique that allows molecular visualization of the distribution of drugs and metabolites in a two-dimensional space directly in biological tissues. Imaging drug distribution inside a tumor is an important tool to support strategies to improve penetration of anticancer drugs and consequently the outcome of chemotherapy. MSI has some advantages in comparison to other imaging techniques, that is, whole body autoradiography, positron emission tomography or microscopy imaging. It is a label-free technique with better specificity and provides the possibility to combine histological data with MS ones and to visualize simultaneously the distribution of biomarkers in relation to tumor heterogeneity. We overview here publications on MSI applied to studies of the distribution of anticancer agents in tumor tissue. In addition, we focused our attention on technical limitations and future perspectives pertaining to this technique.

AB - Mass spectrometry imaging (MSI) is an emerging technique that allows molecular visualization of the distribution of drugs and metabolites in a two-dimensional space directly in biological tissues. Imaging drug distribution inside a tumor is an important tool to support strategies to improve penetration of anticancer drugs and consequently the outcome of chemotherapy. MSI has some advantages in comparison to other imaging techniques, that is, whole body autoradiography, positron emission tomography or microscopy imaging. It is a label-free technique with better specificity and provides the possibility to combine histological data with MS ones and to visualize simultaneously the distribution of biomarkers in relation to tumor heterogeneity. We overview here publications on MSI applied to studies of the distribution of anticancer agents in tumor tissue. In addition, we focused our attention on technical limitations and future perspectives pertaining to this technique.

UR - http://www.scopus.com/inward/record.url?scp=84892971177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892971177&partnerID=8YFLogxK

U2 - 10.1016/j.coph.2013.06.003

DO - 10.1016/j.coph.2013.06.003

M3 - Article

C2 - 23810822

AN - SCOPUS:84892971177

VL - 13

SP - 807

EP - 812

JO - Current Opinion in Pharmacology

JF - Current Opinion in Pharmacology

SN - 1471-4892

IS - 5

ER -